Literature DB >> 17061284

Sickle cell disease as a neurodevelopmental disorder.

Jeffrey Schatz1, Catherine B McClellan.   

Abstract

Sickle cell disease (SCD) is a blood disorder; however, the central nervous system (CNS) is one of the organs frequently affected by the disease. Brain disease can begin early in life and often leads to neurocognitive dysfunction. Approximately one-fourth to one-third of children with SCD have some form of CNS effects from the disease, which typically manifest as deficits in specific cognitive domains and academic difficulties. We discuss SCD as a neurodevelopmental disorder by reviewing the mechanisms of neurological morbidity in SCD, the timing of these mechanisms, the types of cognitive and behavioral morbidity that is typical, and the interaction of social-environmental context with disease processes. The impact of the disease on families shares many features similar to other neurodevelopmental disorders; however, social-environmental factors related to low socioeconomic status, worry and concerns about social stigma, and recurrent, unpredictable medical complications can be sources of relatively higher stress in SCD. Greater public awareness of the neurocognitive effects of SCD and their impact on child outcomes is a critical step toward improved treatment, adaptation to illness, and quality of life. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 17061284     DOI: 10.1002/mrdd.20115

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  18 in total

1.  Cognitive and behavior deficits in sickle cell mice are associated with profound neuropathologic changes in hippocampus and cerebellum.

Authors:  Li Wang; Luis E F Almeida; Celia M de Souza Batista; Alfia Khaibullina; Nuo Xu; Sarah Albani; Kira A Guth; Ji Sung Seo; Martha Quezado; Zenaide M N Quezado
Journal:  Neurobiol Dis       Date:  2015-10-14       Impact factor: 5.996

2.  Disease severity and slower psychomotor speed in adults with sickle cell disease.

Authors:  Dana R Jorgensen; Andrea Metti; Meryl A Butters; Joseph M Mettenburg; Caterina Rosano; Enrico M Novelli
Journal:  Blood Adv       Date:  2017-09-14

3.  Nocturnal oxygen desaturation and disordered sleep as a potential factor in executive dysfunction in sickle cell anemia.

Authors:  Matthew J Hollocks; Tessa B Kok; Fenella J Kirkham; Johanna Gavlak; Baba P Inusa; Michael R DeBaun; Michelle de Haan
Journal:  J Int Neuropsychol Soc       Date:  2011-11-24       Impact factor: 2.892

4.  Does Obstructive Sleep Apnea Increase Cognitive Deficits in Pediatric Sickle Cell Disease?

Authors:  Sarah E Bills; Tal Katz; Jaleel McNeil; Jeffrey Schatz
Journal:  J Int Neuropsychol Soc       Date:  2019-07-30       Impact factor: 2.892

5.  Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia.

Authors:  Elliott P Vichinsky; Lynne D Neumayr; Jeffrey I Gold; Michael W Weiner; Randall R Rule; Diana Truran; Jeffrey Kasten; Barry Eggleston; Karen Kesler; Lillian McMahon; Eugene P Orringer; Thomas Harrington; Karen Kalinyak; Laura M De Castro; Abdullah Kutlar; Cynthia J Rutherford; Cage Johnson; Joel David Bessman; Lanetta B Jordan; F Daniel Armstrong
Journal:  JAMA       Date:  2010-05-12       Impact factor: 56.272

6.  Working Memory in Children With Neurocognitive Effects From Sickle Cell Disease: Contributions of the Central Executive and Processing Speed.

Authors:  Kelsey E Smith; Jeffrey Schatz
Journal:  Dev Neuropsychol       Date:  2016-10-19       Impact factor: 2.253

7.  The burden of obstructive sleep apnea in pediatric sickle cell disease: a Kids' inpatient database study.

Authors:  Po-Yang Tsou; Christopher M Cielo; Melissa S Xanthopoulos; Yu-Hsun Wang; Pei-Lun Kuo; Ignacio E Tapia
Journal:  Sleep       Date:  2021-02-12       Impact factor: 5.849

8.  Auto-adjusting positive airway pressure in children with sickle cell anemia: results of a phase I randomized controlled trial.

Authors:  Melanie J Marshall; Romola S Bucks; Alexandra M Hogan; Ian R Hambleton; Susan E Height; Moira C Dick; Fenella J Kirkham; David C Rees
Journal:  Haematologica       Date:  2009-07       Impact factor: 9.941

Review 9.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

10.  Association of social-environmental factors with cognitive function in children with sickle cell disease.

Authors:  Janet Yarboi; Bruce E Compas; Gene H Brody; Desiree White; Jenny Rees Patterson; Kristen Ziara; Allison King
Journal:  Child Neuropsychol       Date:  2015-11-15       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.